Neumora Therapeutics Overview
Neumora Therapeutics Target Price
Analysts' 12-month price predictions for NMRA.
Get informed when a big investor buys or sells
+ FollowShare Price
$1.78
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-01-12 | Leerink PartnersMarc Goodman | $8 |  349.4% upside |  |
| 2026-01-05 | Mizuho SecuritiesGraig Suvannavejh | $6 | 237.1% upside | |
| 2025-12-01 | RBC Capital | $7 | 293.3% upside | |
| 2025-10-28 | Needham | $8 | 349.4% upside | |
| 2025-03-07 | Stifel Nicolaus | $2 | 12.4% upside | |
| 2025-01-02 | RBC CapitalBrian Abrahams | $4 | 124.7% upside | |
| 2024-07-22 | NeedhamAmi Fadia | $23 | 1192.1% upside | |
| 2024-07-08 | Mizuho SecuritiesGraig Suvannavejh | $20 | 1023.6% upside | |
| 2024-06-17 | RBC CapitalBrian Abrahams | $29 | 1529.2% upside | |
| 2024-03-13 | RBC CapitalBrian Abrahams | $31 | 1641.6% upside | |
| 2023-10-10 | Stifel NicolausPaul Matteis | $26 | 1360.7% upside | |
| 2023-10-10 | RBC CapitalBrian Abrahams | $24 | 1248.3% upside | |